Itraconazole modified - Cellgate

Drug Profile

Itraconazole modified - Cellgate

Latest Information Update: 09 Aug 2007

Price : $50

At a glance

  • Originator Cellgate
  • Class Antifungals; Azoles; Chlorobenzenes; Piperazines; Small molecules; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Onychomycosis

Most Recent Events

  • 09 Aug 2007 Discontinued - Preclinical for Onychomycosis in USA (Topical)
  • 21 Jan 2003 Preclinical trials in Onychomycosis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top